Background Pleural effusion is common in routine medical practice and can be due to many
different underlying diseases. Precise differential diagnostic categorization is essential, as …

Malignant pleural mesothelioma (MPM) is a highly lethal form of pleural cancer
characterized by a scarcity of effective therapeutic interventions, resulting in unfavorable …

Advances in biomarker‐driven therapies for patients with nonsmall cell lung cancer
(NSCLC) both provide opportunities to improve the treatment (and thus outcomes) for …

Background and objective The clinical relevance of pleural effusions in lung cancer has
seldom been approached systematically. The aim of this study was to determine the …

The use of biomarkers on pleural fluid (PF) specimens may assist the decision-making
process and enhance clinical diagnostic pathways. Three paradigmatic examples are heart …

Over the past decade, the growing interest in targeted lung cancer therapy has guided
researchers toward the cutting edge of controlled drug delivery, particularly magnetic …

Background and objectives Pleural infection is a major cause of morbidity and mortality
among adults. Identification of the offending organism is key to appropriate antimicrobial …

Tuberculous pleural effusion (TPE) is the second most common presentation of
extrapulmonary tuberculosis. The paucibacillary nature of the effusion poses diagnostic …

Background Pleural fluid cytology is an important diagnostic test used for the investigation of
pleural effusions. There is considerable variability in the reported sensitivity for the diagnosis …

BACKGROUND The role of fluorodeoxyglucose (FDG)-PET imaging for diagnosing
malignant pleural effusions is not well defined. The aim of this study was to summarize the …